Sitagliptin Phosphate Monohydrate
Generic Name: sitagliptin phosphate monohydrate
Dosage form: POWDER. Active ingredients: SITAGLIPTIN PHOSPHATE (1 kg/kg). Category: BULK INGREDIENT.
Overview
Dosage form: POWDER. Active ingredients: SITAGLIPTIN PHOSPHATE (1 kg/kg). Category: BULK INGREDIENT.
Dosage
Available as powder.
Related Medications
Alirocumab
alirocumab
PCSK9 Inhibitor [EPC]
11 DESCRIPTION Alirocumab is a human monoclonal antibody (IgG1 isotype) that targets proprotein convertase subtilisin kexin type 9 (PCSK9). Alirocumab is a PCSK9 inhibitor produced by recombinant DNA technology in Chinese Hamster Ovary cell suspension culture. Alirocumab consists of two disulfide-linked human heavy chains, each covalently linked through a disulfide bond to a human kappa light chain.
Levalbuterol
levalbuterol
11 DESCRIPTION Levalbuterol inhalation solution, USP is a sterile, clear, colorless, preservative-free solution of the hydrochloride salt of levalbuterol, the (R)-enantiomer of the drug substance racemic albuterol. Levalbuterol hydrochloride is a relatively selective beta 2 -adrenergic receptor agonist [see Clinical Pharmacology (12) ].
Estradiol, Folliculinum, Oophorinum (suis)
estradiol, folliculinum, oophorinum (suis)
Estrogen [EPC]
INDICATIONS: May temporarily relieve excessive bleeding, irregular menses, breast tenderness, dry skin, moodiness, hot flashes, and vaginal dryness and irritation.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.